Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study

The COVID‐19 pandemic has manifold impacts on clinical trials. In response, drug regulatory agencies and public health bodies have issued guidance on how to assess potential impacts on ongoing clinical trials and stress the importance of a risk‐assessment as a pre‐requisite for modifications to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasch, Florian, Guizzaro, Lorenzo, Aguirre Dávila, Lukas, Müller‐Vahl, Kirsten, Koch, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Main Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014297/
https://www.ncbi.nlm.nih.gov/pubmed/33594741
http://dx.doi.org/10.1002/pst.2100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014297/
https://www.ncbi.nlm.nih.gov/pubmed/33594741
http://dx.doi.org/10.1002/pst.2100

Ejemplares similares